Augmented Reality for Subdural Hematoma
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how augmented reality (AR) might help doctors place a subdural drain more accurately in patients with a subdural hematoma, a type of brain bleed. In the first part, researchers will assess the AR system's effectiveness by comparing it to standard methods without altering treatment. In the second part, patients will undergo either the AR-guided or the standard non-AR-guided procedure to determine which method is more effective. Individuals with a subdural hematoma scheduled for treatment with a subdural evacuating portal system (SEPS) and eligible for a CT scan might be suitable for this study. As an unphased trial, this study offers patients the chance to contribute to innovative research that could enhance medical procedures.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that this augmented reality system is safe for subdural drain placement?
Research has shown that using augmented reality (AR) in medical procedures, such as placing a subdural drain, appears promising. Studies have found that AR helps doctors perform these tasks more accurately, potentially reducing mistakes. For instance, one study found that AR-guided procedures were very precise, which could enhance the safety of placing drains.
Although the AR system does not directly treat a condition, it plays a crucial role in the procedure. By aiding doctors in placing the drain more accurately, it may lower the risk of complications associated with this type of surgery.
In summary, early findings suggest that using AR for placing drains is safe and well-tolerated by patients. This offers a hopeful outlook for those considering joining a trial involving this technology.12345Why are researchers excited about this trial?
Researchers are excited about using augmented reality (AR) for subdural drain placement because it could revolutionize how drains are placed in patients with subdural hematoma. Unlike the standard method that relies solely on anatomical guidance, AR provides real-time, 3D visualization, potentially improving precision and accuracy during the procedure. This innovative approach could lead to better patient outcomes by reducing the risk of complications and improving the overall success rate of drain placements. By integrating technology into surgical procedures, this method represents a significant leap forward in the treatment of subdural hematomas.
What evidence suggests that augmented reality is effective for subdural drain placement?
Research has shown that augmented reality (AR) can help doctors place brain drains more accurately, such as those used for subdural hematomas. One study demonstrated that AR successfully guided 11 drain placements on the first try, compared to a 64% success rate without AR. This trial will explore AR use in two parts. In the "Pilot Usability (Part 1)" arm, researchers will test the AR device for functionality without influencing clinical decisions. In the "AR Guided SEPS Placement (Part 2)" arm, AR guidance will assist in placing SEPS drains. Another report highlights how AR allows doctors to see imaging data directly on a patient's head, making it easier to find the right spot for draining. These findings suggest AR could make the procedure safer and more effective.23456
Who Is on the Research Team?
Vivek Buch, MD
Principal Investigator
Stanford University
Are You a Good Fit for This Trial?
This trial is for individuals with a subdural hematoma, which is a type of brain bleed that requires drainage. Participants must be candidates for a procedure using the Subdural Evacuating Portal System (SEPS). They cannot join if they are unable to undergo CT scans or if they are pregnant.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pilot Usability
Five patients will be enrolled to test whether the AR device functions appropriately, but no clinical decisions or changes to care will be determined by the AR device at this point.
Treatment
Participants are randomized to AR-guided and non-AR-guided SEPS placement to determine efficacy.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including symptom score assessment and radiographic measures.
What Are the Treatments Tested in This Trial?
Interventions
- Augmented Reality for Subdural Drain Placement
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor